—
C+
C+ The full Closelooknet — membership. Open the C+ overview

BridgeBio Pharma Inc（BBIO）— 技术面状态

数据截至2026-11-02 — 每个交易日晚间对全部覆盖范围重新计算。Closelook研究日记，不构成投资建议。

Recovery attempt under the 200-day

Trades +6.9% vs the 50-day and +3.1% vs the 200-day average, 19.7% below the 52-week high and +24.5% off the 52-week low; a death cross printed 12 sessions ago. Computed from daily closes.

均线状态

相关页面： BBIO图表与概览 · 质量与财务体检 · 财报反应记录 · 信号看板

FAQ · from the current data · as of 2026-11-02

Quick answers

BBIO当前的Closelook信号是什么？

Recovery attempt under the 200-day — Trades +6.9% vs the 50-day and +3.1% vs the 200-day average, 19.7% below the 52-week high and +24.5% off the 52-week low; a death cross printed 12 sessions ago. Computed from daily closes.（截至2026-11-02；信号看板每个交易日晚间对全部覆盖范围重新计算。研究日记读数，不构成投资建议。）

BBIO目前是否位于50日和200日均线上方？

截至2026-11-02，BridgeBio Pharma Inc位于50日均线上方（+6.9%），200日均线上方（+3.1%）；距20日均线+10.3%。

BBIO距52周高点有多远？

截至2026-11-02，低于52周高点19.7%，高于52周低点24.5%。

Related in the Closelooknet universe

then Biotechnology. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.